Study of BMN 349 Single Dose in PiZZ and PiMZ/MASH Adult Participants

Clinical trial NCT06738017 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06738017
Sponsor: BioMarin Pharmaceutical
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alpha 1-Antitrypsin Deficiency

Start date: 2025-02-21
Primary completion: 2026-08-19
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.